Skip to main content
SpringerLink
Log in
Book cover

The Thyroid and Its Diseases pp 281–292Cite as

Myxedema Coma

  • Chapter
  • First Online:

Abstract

Myxedema coma is the most severe form of hypothyroidism and carries a high mortality risk. Patients are typically elderly women who present in winter with deteriorating mental status, hypothermia, bradycardia, and multisystem organ failure. Aggressive therapy is required to avoid a fatal outcome.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   189.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD   249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Ord WM. Report of a committee of the Clinical Society of London to investigate the subject of myxedema. Trans Clin Soc (Lond). 1888;21:1–215.

    Google Scholar 

  2. LeMarquand HS, Hausmann W, Hemstead EH. Myxedema as a cause of death. BMJ. 1953;1:704–6.

    Article  CAS  Google Scholar 

  3. Summers VK. Myxedema coma. BMJ. 1953;2:336–8.

    Article  Google Scholar 

  4. Kwaku MP, Burman KD. Myxedema coma. J Intensive Care Med. 2007;22:224–31.

    Article  PubMed  Google Scholar 

  5. Rodriguez I, Fluiters E, Perez-Mendez LF, et al. Factors associated with mortality of patients with myxedema coma: prospective study in 11 cases treated in a single institution. J Endocrinol. 2004;80:347–50.

    Article  Google Scholar 

  6. Blignault EJ. Advanced pregnancy in severely myxedematous patient. A case report and review of the literature. S Afr Med J. 1980;57:1050–1.

    CAS  PubMed  Google Scholar 

  7. Patel S, Robinson S, Bidgood RJ, et al. A pre-eclamptic-like syndrome associated with hypothyroidism during pregnancy. Q J Med. 1991;79:435–41.

    CAS  PubMed  Google Scholar 

  8. Mathew V, Misgar RA, Ghosh S, et al. Myxedema coma: a new look into an old crisis. J Thyroid Res. 2011;2011:493462.

    Article  PubMed Central  PubMed  Google Scholar 

  9. Church CO, Callen EC. Myxedema coma associated with combination aripiprazole and sertraline therapy. Ann Pharmacother. 2009;43:2113–6.

    Article  PubMed  Google Scholar 

  10. Chu M, Seltzer TF. Myxedema coma induced by ingestion of raw bok choy. N Engl J Med. 2010;362(20):1945–6.

    Article  CAS  PubMed  Google Scholar 

  11. Klubo-Gwiezdzinska J, Wartofsky L. Myxedema coma. In: Wass JAH, Stewart PM, Amiel SA, Davies MJ, editors. Oxford textbook of endocrinology and diabetes. 2nd ed. Oxford: Oxford Univ. Press; 2011;343:537–543.

    Google Scholar 

  12. Reinhardt W, Mann K. Incidence, clinical picture and treatment of hypothyroid coma. Results of a survey. Med Klin. 1997;92:521–4.

    Article  CAS  Google Scholar 

  13. Jansen HJ, Doebe SR, Louwerse ES, et al. Status epilepticus caused by a myxedema coma. Neth J Med. 2006;64:202–5.

    CAS  PubMed  Google Scholar 

  14. Zwillich CW, Pierson DJ, Hofeldt FD, et al. Ventilatory control in myxedema and hypothyroidism. N Engl J Med. 1975;292:662–5.

    Article  CAS  PubMed  Google Scholar 

  15. Ladenson PW, Goldenheim PD, Ridgway EC. Prediction of reversal of blunted respiratory responsiveness in patients with hypothyroidism. Am J Med. 1988;84:877–83.

    Article  CAS  PubMed  Google Scholar 

  16. Birring SS, Patel RB, Parker D, et al. Airway function and markers of airway inflammation in patients with treated hypothyroidism. Thorax. 2005;60:249–53.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  17. Schenck JB, Rizvi AA, Lin T. Severe primary hypothyroidism manifesting with torsades de pointes. Am J Med Sci. 2006;331:154–6.

    Article  PubMed  Google Scholar 

  18. Urquhart AD, Rea IM, Lawson LT, et al. A new complication of hypothyroid coma: neurogenic dysphagia: presentation, diagnosis, and treatment. Thyroid. 2001;11:595–8.

    Article  CAS  PubMed  Google Scholar 

  19. Chadha JS, Ashby DW, Cowan WK. Fatal intestinal atony in myxoedema. Brit Med J. 1969;3:398.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  20. Ji JS, Chae HS, Cho YS, et al. Myxedema ascites: case report and literature review. J Korean Med Sci. 2006;21(4):761.

    Article  PubMed Central  PubMed  Google Scholar 

  21. Fukunaga K. Refractory gastrointestinal bleeding treated with thyroid hormone replacement. J Clin Gastroenterol. 2001;33:145–7.

    Article  CAS  PubMed  Google Scholar 

  22. Bergeron E, Mitchell A, Heyen F, et al. Acute colonic surgery and unrecognized hypothyroidism: a warning. Report of six cases. Dis Colon Rectum. 1997;40:859–61.

    Article  CAS  PubMed  Google Scholar 

  23. Skowsky RW, Kikuchi TA. The role of vasopressin in the impaired water excretion of myxedema. Am J Med. 1978;64:613–21.

    Article  CAS  PubMed  Google Scholar 

  24. FR DR Jr, Michelis MF, Bloom ME, et al. Impaired water excretion in myxedema. Am J Med. 1971;51:41–53.

    Article  Google Scholar 

  25. Ardalan MR, Ghabili K, Mirnour R, et al. Hypothyroidism-induced rhabdomyolysis and renal failure. Ren Fail. 2011;33:553–4.

    Article  PubMed  Google Scholar 

  26. Nikolaidou C, Gouridou E, Ilonidis G, et al. Acute renal dysfunction in a patient presenting with rhabdomyolysis due to Hypothyroidism attributed to Hashimoto’s disease. Hippokratia. 2010;4:281–3.

    Google Scholar 

  27. Birewar S, Oppenheimer M, Zawada ET Jr. Hypothyroid acute renal failure. SDJ Med. 2004;57:109–10.

    Google Scholar 

  28. Kar PM, Hirani A, Allen MJ. Acute renal failure in a hypothyroid patient with rhabdomyolysis. Clin Nephrol. 2003;60:428–9.

    Article  CAS  PubMed  Google Scholar 

  29. Manfredi E, van Zaane B, Gerdes VE, et al. A hypothyroidism and acquired von Willebrand’s syndrome: a systematic review. Haemophilia. 2008;14:423–33.

    Article  CAS  PubMed  Google Scholar 

  30. Michiels JJ, Schroyens W, Berneman Z, et al. Acquired von Willebrand syndrome type 1 in hypothyroidism: reversal after treatment with thyroxine. Clin Appl Thromb Hemost. 2001;7:113–5.

    Article  CAS  PubMed  Google Scholar 

  31. Dutta P, Bhansali A, Masoodi SR, et al. Predictors of outcome in myxedema coma: a study from a tertiary care centre. Crit Care. 2008;12(R1):1–8.

    Article  Google Scholar 

  32. Yamamoto T, Fukuyama J, Fujiyoshi A. Factors associated with mortality of myxedema coma: report of eight cases and literature survey. Thyroid. 1999;9:1167–74.

    Article  CAS  PubMed  Google Scholar 

  33. Sanders V. Neurologic manifestations of myxedema. N Engl J Med. 1962;266:547–51.

    Article  Google Scholar 

  34. Hooper MJ. Diminished TSH secretion during acute non-thyroidal illness in untreated primary hypothyroidism. Lancet. 1976:48–9.

    Article  Google Scholar 

  35. Wartofsky L, Burman KD. Alterations in thyroid function in patients with systemic illness: the ‘euthyroid sick syndrome’. Endocr Rev. 1982;3:164–217.

    Article  CAS  PubMed  Google Scholar 

  36. Popoveniuc G, Chandra T, Sud A, Sharma M, Blackman MR, Burman KD, Wartofsky L. A diagnostic scoring system for patients with myxedema coma. Endocr Pract. 2014;8:808–17.

    Article  Google Scholar 

  37. Nicoloff JT. Thyroid storm and myxedema coma. Med Clin North Am. 1985;69:1005–17.

    Article  CAS  PubMed  Google Scholar 

  38. Vachharajani TJ, Zaman F, Abreo KD. Hyponatremia in critically ill patients. J Intensive Care Med. 2003;18:3–8.

    Article  CAS  PubMed  Google Scholar 

  39. Pereira VG, Haron ES, Lima-Neto N, et al. Management of myxedema coma: report on three successfully treated cases with nasogastric or intravenous administration of triiodothyronine. J Endocrinol Investig. 1982;5:331–4.

    Article  CAS  Google Scholar 

  40. Verbalis JG, Goldsmith SR, Greenberg A, et al. Hyponatremia treatment guidelines 2007: expert panel recommendations. Am J Med. 2007;120:1–21.

    Article  Google Scholar 

  41. Vaprisol (conivaptan HCl injection). Package insert. Deerfield, IL, Astellas Tokai Co; 2006.

    Google Scholar 

  42. Hline SS, Pham PT, Pham PT, et al. Conivaptan: a step forward in the treatment of hyponatremia. Ther Clin Risk Manag. 2008;4:315–26.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  43. Li-Ng M, Verbalis JG. Conivaptan: evidence supporting its therapeutic use in hyponatremia. Core Evid. 2010;4:83–92.

    PubMed  PubMed Central  Google Scholar 

  44. Kamilaris TC, DeBold CR, Pavlou SN, et al. Effect of altered thyroid hormone levels on hypothalamic-pituitary-adrenal function. J Clin Endocrinol Metab. 1987;65:994–9.

    Article  CAS  PubMed  Google Scholar 

  45. Bigos ST, Ridgway EC, Kourides IA, et al. Spectrum of pituitary alterations with mild and severe thyroid impairment. J Clin Endocrinol Metab. 1978;46:317–25.

    Article  CAS  PubMed  Google Scholar 

  46. Holvey DN, Goodner CJ, Nicoloff JT, et al. Treatment of myxedema coma with intravenous thyroxine. Arch Intern Med. 1964;113:139–46.

    Article  Google Scholar 

  47. Rodriguez I, Fluiters E, Perez-Mendez LF, et al. Factors associated with mortality of patients with myxoedema coma: prospective study in 11 cases treated in a single institution. J Endocrinol. 2004;180:347–50.

    Article  CAS  PubMed  Google Scholar 

  48. Hylander B, Rosenqvist U. Treatment of myxedema coma: factors associated with fatal outcome. Acta Endocrinol. 1985;108:65–71.

    Article  CAS  Google Scholar 

  49. Blackburn CM, McConahey WM, Keating RF. Calorigenic effects of single intravenous doses of L-triiodothyronine and L-thyroxine in myxedematous persons. J Clin Invest. 1954;33:819–24.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  50. Chernow B, Burman KD, Johnson DL, et al. T3 may be a better agent than T4 in the critically ill hypothyroid patient: evaluation of transport across the blood-brain barrier in a primate model. Crit Care Med. 1983;11:99–104.

    Article  CAS  PubMed  Google Scholar 

  51. McKerrow SD, Osborn LA, Levy H, et al. Myxedema-associated cardiogenic shock treated with triiodothyronine. Ann Intern Med. 1992;117:1014–5.

    Article  Google Scholar 

  52. Wartofsky L. Myxedema coma. Endocrinol Metab Clin N Am. 2006;35:687–98.

    Article  CAS  Google Scholar 

  53. McCulloch W, Price P, Hinds CJ, et al. Effects of low dose oral triiodothyronine in myxedema coma. Intensive Care Med. 1985;11:259–62.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Georgetown University School of Medicine, Washington, DC, USA

    Leonard Wartofsky & Joanna Klubo-Gwiezdzinska

  2. Thyroid Cancer Research Unit, MedStar Health Research Institute, Washington, DC, USA

    Leonard Wartofsky

  3. National Institutes of Health—National Institute of Diabetes and Digestive and Kidney Disease, Bethesda, MD, USA

    Joanna Klubo-Gwiezdzinska

Authors
  1. Leonard Wartofsky
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Joanna Klubo-Gwiezdzinska
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Leonard Wartofsky .

Editor information

Editors and Affiliations

  1. Department of Nuclear Medicine, Philipps University Marburg, Marburg, Germany

    Markus Luster

  2. Unit of Endocrinology Diabetes and Metabolism, Evgenidion Hospital, National and Kapodistrian University of Athens, Athens, Greece

    Leonidas H. Duntas

  3. Georgetown University School of Medicine, Washington, DC, USA

    Leonard Wartofsky

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Wartofsky, L., Klubo-Gwiezdzinska, J. (2019). Myxedema Coma. In: Luster, M., Duntas, L., Wartofsky, L. (eds) The Thyroid and Its Diseases. Springer, Cham. https://doi.org/10.1007/978-3-319-72102-6_20

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-72102-6_20

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-72100-2

  • Online ISBN: 978-3-319-72102-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation